Company Filing History:

12 out of 117

Wockhardt Limited

The Company of Wockhardt Limited

patent

Years Active: 2003-2014

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8729269 - Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy (2014-05-20),

2. 7687627 - Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy (2010-03-30),

3. 7626032 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2009-12-01),

4. 7538221 - Polymorphs of racemic, dextrorotatory, and levorotatory enantioners of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesylate salts (2009-05-26),

5. 7405228 - Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites (2008-07-29),

6. 7393957 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2008-07-01),

7. 7247642 - Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment (2007-07-24),

8. 7098219 - Inhibitors of cellular efflux pumps of microbes (2006-08-29),

9. 6987167 - Process for production of the somatostatin analog, octreotide (2006-01-17),

10. 6964966 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2005-11-15),

11. 6878713 - Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments (2005-04-12),

12. 6753333 - Chiral fluoroquinolone arginine salt forms (2004-06-22),

13. 6750224 - Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment (2004-06-15),

14. 6608078 - Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment (2003-08-19),

Title: Noel John De Souza: A Pioneer in Antimicrobial Innovation

Introduction

Noel John De Souza is an accomplished inventor based in Mumbai, India, recognized for his significant contributions in the field of antimicrobial agents. With an impressive portfolio of 14 patents, he has dedicated his career to advancing medical therapeutics and improving the efficacy of treatments for infectious diseases.

Latest Patents

Among his latest innovations are the "Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy." This groundbreaking invention focuses on novel substituted piperidino phenyloxazolidinone derivatives that exhibit antimicrobial properties. The developed compositions are aimed at preventing and treating infectious diseases, providing processes for synthesizing these compounds, and establishing methods for treating bacterial infections efficiently.

Career Highlights

Throughout his career, Noel John De Souza has held pivotal roles at Wockhardt Limited, a leading pharmaceutical company known for its robust research and development programs. His work in this environment has propelled significant advancements in antimicrobial technology and therapeutic solutions.

Collaborations

De Souza has collaborated with fellow innovators such as Mahesh Vithalbhai Patel and Prasad Keshav Deshpande. These collaborations have fostered a creative environment for the exchange of ideas and expertise, further enriching the field of pharmaceutical sciences.

Conclusion

Noel John De Souza stands out as a visionary inventor dedicated to enhancing healthcare solutions through innovative inventions. His ongoing commitment to research and development continues to pave the way for new treatments, showcasing the important role of inventors in advancing medical science and public health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com